{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:49:06Z","timestamp":1780631346560,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41433-025-03934-8","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T19:16:32Z","timestamp":1752779792000},"page":"2599-2603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-term follow-up of circumscribed iris melanomas treated by proton beam therapy"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2626-949X","authenticated-orcid":false,"given":"Livia","family":"Lumbroso-Le Rouic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Maynadier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Goudjil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Dendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Matet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Dureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cassoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"3934_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.survophthal.2016.12.012","volume":"62","author":"M Popovic","year":"2017","unstructured":"Popovic M, Ahmed IIK, DiGiovanni J, Shields CL. Radiotherapeutic and surgical management of iris melanoma: a review. Surv Ophthalmol. 2017;62:302\u201311.","journal-title":"Surv Ophthalmol"},{"key":"3934_CR2","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/sj.eye.6702102","volume":"20","author":"L Lumbroso-Le Rouic","year":"2006","unstructured":"Lumbroso-Le Rouic L, Delacroix S, Dendale R, Levy-Gabriel C, Feuvret L, Noel G, et al. Proton beam therapy for iris melanomas. Eye. 2006;20:1300\u20135.","journal-title":"Eye"},{"key":"3934_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijrobp.2005.01.050","volume":"63","author":"B Damato","year":"2005","unstructured":"Damato B, Kacperek A, Chopra M, Sheen MA, Campbell IR, Errington RD. Proton beam radiotherapy of iris melanoma. Int J Radiat Oncol Biol Phys. 2005;63:109\u201315. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.01.050.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3934_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ophtha.2017.10.009","volume":"125","author":"J Thariat","year":"2018","unstructured":"Thariat J, Rahmi A, Salleron J, Mosci C, Butet B, Maschi C, et al. Proton beam therapy for iris melanomas in 107 patients. Ophthalmology. 2018;125:606\u201314.","journal-title":"Ophthalmology"},{"key":"3934_CR5","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/bjophthalmol-2014-305174","volume":"99","author":"GD Willerding","year":"2015","unstructured":"Willerding GD, Cordini D, Hackl C, Karle B, Lakotka N, Foerster MH, et al. Proton beam radiotherapy of diffuse iris melanoma in 54 patients. Br J Ophthalmol. 2015;99:812\u20136.","journal-title":"Br J Ophthalmol"},{"key":"3934_CR6","doi-asserted-by":"publisher","first-page":"021","DOI":"10.1186\/s12885-021-09002-0","volume":"21","author":"S Sabazade","year":"2021","unstructured":"Sabazade S, Herrspiegel C, Gill V, St\u00c3\u00a5lhammar G. No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter. BMC Cancer. 2021;21:021\u201309002.","journal-title":"BMC Cancer"},{"key":"3934_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ajoc.2018.12.007","volume":"13","author":"Msika","year":"2018","unstructured":"Msika LC, Desjardins L, Cockenpot V, Dendale R, Berges O, A\u00c3\u00aft Ra\u00c3\u00afs K, et al. Iris melanoma relapsing sixteen years after proton-beam therapy: the importance of lifelong follow-up. Am J Ophthalmol Case Rep. 2018;13:89\u201392.","journal-title":"Am J Ophthalmol Case Rep"},{"key":"3934_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.survophthal.2003.08.001","volume":"48","author":"FA Marigo","year":"2003","unstructured":"Marigo FA, Finger PT. Anterior segment tumors: current concepts and innovations. Surv Ophthalmol. 2003;48:569\u201393.","journal-title":"Surv Ophthalmol"},{"key":"3934_CR9","unstructured":"Shields J, Shields C. Melanocytic tumors of the iris stroma. In: Intraocular tumors A text and atlas. Philadelphia, Pennsylvania: Saunders; 1992. p. 69\u201377."},{"key":"3934_CR10","first-page":"00452","volume":"6530","author":"J Gollrad","year":"2022","unstructured":"Gollrad J, Boeker A, Vitzthum S, Besserer A, Heufelder J, Gauger U, et al. Proton therapy for 166 patients with iris melanoma: side effects and oncological outcome. Ophthalmol Retin. 2022;6530:00452\u20133.","journal-title":"Ophthalmol Retin"},{"key":"3934_CR11","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ophtha.2023.05.004","volume":"130","author":"K Eibenberger","year":"2023","unstructured":"Eibenberger K, Heimann H, Gatchalian L, Kacperek A, Hussain R. Side effects of proton beam radiotherapy treatment on iris melanoma. Ophthalmology. 2023;130:958\u201365.","journal-title":"Ophthalmology"},{"key":"3934_CR12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/bjophthalmol-2013-303321","volume":"98","author":"MT Sandinha","year":"2014","unstructured":"Sandinha MT, Kacperek A, Errington RD, Coupland SE, Damato B. Recurrence of iris melanoma after proton beam therapy. Br J Ophthalmol. 2014;98:484\u20137.","journal-title":"Br J Ophthalmol"},{"key":"3934_CR13","unstructured":"Kivela T, Simpson ER, Grossniklaus HE, Jager MJ, Singh AD, Caminal JM, Pavlick AC, et al. PT Finger Uveal melanoma. In: Amin M, editor. AJCC cancer staging manual, 8th ed. New York (NY): Springer; 2017. p. 805\u201317."},{"key":"3934_CR14","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.ophtha.2017.11.040","volume":"125","author":"CL Shields","year":"2018","unstructured":"Shields CL, Di Nicola M, Bekerman VP, Kaliki S, Alarcon C, Fulco E, et al. Iris melanoma outcomes based on the American Joint Committee on cancer classification (eighth edition) in 432 patients. Ophthalmology. 2018;125:913\u201323.","journal-title":"Ophthalmology"},{"key":"3934_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ophtha.2012.06.053","volume":"120","author":"CL Shields","year":"2013","unstructured":"Shields CL, Shah SU, Bianciotto CG, Emrich J, Komarnicky L, Shields JA. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes. Ophthalmology. 2013;120:55\u201361.","journal-title":"Ophthalmology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03934-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03934-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03934-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:44:06Z","timestamp":1757252646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03934-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":15,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3934"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-03934-8","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"18 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}